Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Sell

Wall Street Data Solutions Rating

Neutral

B

ICU Medical Inc (ICUI)

Surgical & Medical Instruments & Apparatus

https://www.icumed.com

ICU Medical is a California-based, pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017, and Smiths Medical from Smiths Group in 2022. It holds top-tier positions in its original reporting segments: infusion consumables (25% of 2022 revenue), IV solutions (16%), infusion systems (15%), and critical care (2%) as well as its new Smiths segments: Smiths infusion systems (15%), vascular access (14%), and vital care (12%). The combined entity remains primarily U.S. focused, generating over 64% of its sales domestically.

951 CALLE AMANECER
SAN CLEMENTE, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

03/31/1992

Market Cap

3,856,510,617

Shares Outstanding

24,140,000

Weighted SO

24,140,076

Total Employees

N/A

Upcoming Earnings

08/05/2024

Similar Tickers

MMSI --.--%

COO --.--%

ANGO --.--%

ATR --.--%

HOLX --.--%

HAE --.--%

NVST --.--%

AKYA --.--%

ATRC --.--%

Beta

0.6960

Last Div

0.0000

Range

78.28-159.5

Chg

-0.2300

Avg Vol

335851

Mkt Cap

3856510617

Exch

NASDAQ

Country

US

Phone

949 366 2183

DCF Diff

-55.3435

DCF

213.2234

Div Yield

0.0000

P/S

1.6745

EV Multiple

21.4379

P/FV

1.8900

Div Yield %

0.0000

P/E

-54.4092

PEG

-2.8551

Payout

-0.1622

Current Ratio

2.4047

Quick Ratio

1.0708

Cash Ratio

0.5912

DSO

24.5551

DIO

158.5187

Op Cycle

183.0739

DPO

36.1006

CCC

146.9732

Gross Margin

0.3173

Op Margin

0.0131

Pretax Margin

-0.0427

Net Margin

-0.0307

Eff Tax Rate

0.2802

ROA

-0.0165

ROE

-0.0340

ROCE

0.0080

NI/EBT

0.7198

EBT/EBIT

-3.2576

EBIT/Rev

0.0131

Debt Ratio

0.3790

D/E

0.7973

LT Debt/Cap

0.4328

Total Debt/Cap

0.4436

Int Coverage

0.5049

CF/Debt

0.1564

Equity Multi

2.1036

Rec Turnover

14.8645

Pay Turnover

10.1106

Inv Turnover

2.3026

FA Turnover

3.4697

Asset Turnover

0.5373

OCF/Share

10.4200

FCF/Share

6.4321

Cash/Share

24.8143

OCF/Sales

0.1104

FCF/OCF

0.6173

CF Coverage

0.1564

ST Coverage

3.6356

CapEx Coverage

2.6129

Div&CapEx Cov

2.3371

P/BV

1.8900

P/B

1.8900

P/S

1.6745

P/E

-54.4092

P/FCF

24.5797

P/OCF

15.1527

P/CF

15.1527

PEG

-2.8551

P/S

1.6745

EV Multiple

21.4379

P/FV

1.8900

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. May 15, 01:00 Bragar Eagel & Squire, P.C. Is Investigating Organon, Aldeyra, Landstar, and ICU Medical and Encourages Investors to Contact the Firm GlobeNewswire Inc. Feb 18, 04:51 Patient Temperature Management Market to Reach $6.5 Billion, Globally, by 2035 at 6.3% CAGR: Allied Market Research Benzinga Nov 06, 13:35 Stocks Fight To Extend Winning Streak, Treasury Yields Rise: What's Driving Markets Monday?

Revenue Product Segmentation